Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2023-2029

Page: 108

Published Date: 04 Sep 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Biologics Contract Manufacturing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.

This report studies the global Biologics Contract Manufacturing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biologics Contract Manufacturing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics Contract Manufacturing that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Biologics Contract Manufacturing total market, 2018-2029, (USD Million)
Global Biologics Contract Manufacturing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biologics Contract Manufacturing total market, key domestic companies and share, (USD Million)
Global Biologics Contract Manufacturing revenue by player and market share 2018-2023, (USD Million)
Global Biologics Contract Manufacturing total market by Type, CAGR, 2018-2029, (USD Million)
Global Biologics Contract Manufacturing total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Biologics Contract Manufacturing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim and Recipharm Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics Contract Manufacturing market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biologics Contract Manufacturing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Biologics Contract Manufacturing Market, Segmentation by Type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Molecular Therapy
Others

Global Biologics Contract Manufacturing Market, Segmentation by Application
Medical Company
Hospital

Companies Profiled:
Lonza Group
Samsung Biologics Co., Ltd.
Thermo Fisher Scientific, Inc.
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.

Key Questions Answered
1. How big is the global Biologics Contract Manufacturing market?
2. What is the demand of the global Biologics Contract Manufacturing market?
3. What is the year over year growth of the global Biologics Contract Manufacturing market?
4. What is the total value of the global Biologics Contract Manufacturing market?
5. Who are the major players in the global Biologics Contract Manufacturing market?

Table of Contents

1 Supply Summary
    1.1 Biologics Contract Manufacturing Introduction
    1.2 World Biologics Contract Manufacturing Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Biologics Contract Manufacturing Total Market by Region (by Headquarter Location)
        1.3.1 World Biologics Contract Manufacturing Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Biologics Contract Manufacturing Market Size (2018-2029)
        1.3.3 China Biologics Contract Manufacturing Market Size (2018-2029)
        1.3.4 Europe Biologics Contract Manufacturing Market Size (2018-2029)
        1.3.5 Japan Biologics Contract Manufacturing Market Size (2018-2029)
        1.3.6 South Korea Biologics Contract Manufacturing Market Size (2018-2029)
        1.3.7 ASEAN Biologics Contract Manufacturing Market Size (2018-2029)
        1.3.8 India Biologics Contract Manufacturing Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Biologics Contract Manufacturing Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Biologics Contract Manufacturing Major Market Trends

2 Demand Summary
    2.1 World Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.2 World Biologics Contract Manufacturing Consumption Value by Region
        2.2.1 World Biologics Contract Manufacturing Consumption Value by Region (2018-2023)
        2.2.2 World Biologics Contract Manufacturing Consumption Value Forecast by Region (2024-2029)
    2.3 United States Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.4 China Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.5 Europe Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.6 Japan Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.7 South Korea Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.8 ASEAN Biologics Contract Manufacturing Consumption Value (2018-2029)
    2.9 India Biologics Contract Manufacturing Consumption Value (2018-2029)

3 World Biologics Contract Manufacturing Companies Competitive Analysis
    3.1 World Biologics Contract Manufacturing Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Biologics Contract Manufacturing Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Biologics Contract Manufacturing in 2022
        3.2.3 Global Concentration Ratios (CR8) for Biologics Contract Manufacturing in 2022
    3.3 Biologics Contract Manufacturing Company Evaluation Quadrant
    3.4 Biologics Contract Manufacturing Market: Overall Company Footprint Analysis
        3.4.1 Biologics Contract Manufacturing Market: Region Footprint
        3.4.2 Biologics Contract Manufacturing Market: Company Product Type Footprint
        3.4.3 Biologics Contract Manufacturing Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Biologics Contract Manufacturing Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Biologics Contract Manufacturing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Biologics Contract Manufacturing Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Biologics Contract Manufacturing Consumption Value Comparison
        4.2.1 United States VS China: Biologics Contract Manufacturing Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Biologics Contract Manufacturing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Biologics Contract Manufacturing Companies and Market Share, 2018-2023
        4.3.1 United States Based Biologics Contract Manufacturing Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Biologics Contract Manufacturing Revenue, (2018-2023)
    4.4 China Based Companies Biologics Contract Manufacturing Revenue and Market Share, 2018-2023
        4.4.1 China Based Biologics Contract Manufacturing Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Biologics Contract Manufacturing Revenue, (2018-2023)
    4.5 Rest of World Based Biologics Contract Manufacturing Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Biologics Contract Manufacturing Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Biologics Contract Manufacturing Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Biologics Contract Manufacturing Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Monoclonal Antibodies
        5.2.2 Recombinant Proteins
        5.2.3 Vaccines
        5.2.4 Molecular Therapy
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Biologics Contract Manufacturing Market Size by Type (2018-2023)
        5.3.2 World Biologics Contract Manufacturing Market Size by Type (2024-2029)
        5.3.3 World Biologics Contract Manufacturing Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Biologics Contract Manufacturing Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Medical Company
        6.2.2 Hospital
    6.3 Market Segment by Application
        6.3.1 World Biologics Contract Manufacturing Market Size by Application (2018-2023)
        6.3.2 World Biologics Contract Manufacturing Market Size by Application (2024-2029)
        6.3.3 World Biologics Contract Manufacturing Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Lonza Group
        7.1.1 Lonza Group Details
        7.1.2 Lonza Group Major Business
        7.1.3 Lonza Group Biologics Contract Manufacturing Product and Services
        7.1.4 Lonza Group Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Lonza Group Recent Developments/Updates
        7.1.6 Lonza Group Competitive Strengths & Weaknesses
    7.2 Samsung Biologics Co., Ltd.
        7.2.1 Samsung Biologics Co., Ltd. Details
        7.2.2 Samsung Biologics Co., Ltd. Major Business
        7.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Services
        7.2.4 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Samsung Biologics Co., Ltd. Recent Developments/Updates
        7.2.6 Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
    7.3 Thermo Fisher Scientific, Inc.
        7.3.1 Thermo Fisher Scientific, Inc. Details
        7.3.2 Thermo Fisher Scientific, Inc. Major Business
        7.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product and Services
        7.3.4 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
        7.3.6 Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
    7.4 Cambrex Corporation
        7.4.1 Cambrex Corporation Details
        7.4.2 Cambrex Corporation Major Business
        7.4.3 Cambrex Corporation Biologics Contract Manufacturing Product and Services
        7.4.4 Cambrex Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Cambrex Corporation Recent Developments/Updates
        7.4.6 Cambrex Corporation Competitive Strengths & Weaknesses
    7.5 Siegfried Holding AG
        7.5.1 Siegfried Holding AG Details
        7.5.2 Siegfried Holding AG Major Business
        7.5.3 Siegfried Holding AG Biologics Contract Manufacturing Product and Services
        7.5.4 Siegfried Holding AG Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Siegfried Holding AG Recent Developments/Updates
        7.5.6 Siegfried Holding AG Competitive Strengths & Weaknesses
    7.6 Fujifilm Holding Corporation
        7.6.1 Fujifilm Holding Corporation Details
        7.6.2 Fujifilm Holding Corporation Major Business
        7.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Services
        7.6.4 Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Fujifilm Holding Corporation Recent Developments/Updates
        7.6.6 Fujifilm Holding Corporation Competitive Strengths & Weaknesses
    7.7 AbbVie, Inc.
        7.7.1 AbbVie, Inc. Details
        7.7.2 AbbVie, Inc. Major Business
        7.7.3 AbbVie, Inc. Biologics Contract Manufacturing Product and Services
        7.7.4 AbbVie, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 AbbVie, Inc. Recent Developments/Updates
        7.7.6 AbbVie, Inc. Competitive Strengths & Weaknesses
    7.8 Boehringer Ingelheim
        7.8.1 Boehringer Ingelheim Details
        7.8.2 Boehringer Ingelheim Major Business
        7.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Product and Services
        7.8.4 Boehringer Ingelheim Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Boehringer Ingelheim Recent Developments/Updates
        7.8.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.9 Recipharm Pharmaceuticals
        7.9.1 Recipharm Pharmaceuticals Details
        7.9.2 Recipharm Pharmaceuticals Major Business
        7.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Services
        7.9.4 Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Recipharm Pharmaceuticals Recent Developments/Updates
        7.9.6 Recipharm Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 WuXi Biologics
        7.10.1 WuXi Biologics Details
        7.10.2 WuXi Biologics Major Business
        7.10.3 WuXi Biologics Biologics Contract Manufacturing Product and Services
        7.10.4 WuXi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 WuXi Biologics Recent Developments/Updates
        7.10.6 WuXi Biologics Competitive Strengths & Weaknesses
    7.11 Catalent, Inc.
        7.11.1 Catalent, Inc. Details
        7.11.2 Catalent, Inc. Major Business
        7.11.3 Catalent, Inc. Biologics Contract Manufacturing Product and Services
        7.11.4 Catalent, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Catalent, Inc. Recent Developments/Updates
        7.11.6 Catalent, Inc. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Biologics Contract Manufacturing Industry Chain
    8.2 Biologics Contract Manufacturing Upstream Analysis
    8.3 Biologics Contract Manufacturing Midstream Analysis
    8.4 Biologics Contract Manufacturing Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Biologics Contract Manufacturing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Biologics Contract Manufacturing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Biologics Contract Manufacturing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Biologics Contract Manufacturing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Biologics Contract Manufacturing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Biologics Contract Manufacturing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Biologics Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Biologics Contract Manufacturing Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Biologics Contract Manufacturing Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Biologics Contract Manufacturing Players in 2022
    Table 12. World Biologics Contract Manufacturing Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Biologics Contract Manufacturing Company Evaluation Quadrant
    Table 14. Head Office of Key Biologics Contract Manufacturing Player
    Table 15. Biologics Contract Manufacturing Market: Company Product Type Footprint
    Table 16. Biologics Contract Manufacturing Market: Company Product Application Footprint
    Table 17. Biologics Contract Manufacturing Mergers & Acquisitions Activity
    Table 18. United States VS China Biologics Contract Manufacturing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Biologics Contract Manufacturing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Biologics Contract Manufacturing Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Biologics Contract Manufacturing Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Biologics Contract Manufacturing Revenue Market Share (2018-2023)
    Table 23. China Based Biologics Contract Manufacturing Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Biologics Contract Manufacturing Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Biologics Contract Manufacturing Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Biologics Contract Manufacturing Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Biologics Contract Manufacturing Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Biologics Contract Manufacturing Revenue Market Share (2018-2023)
    Table 29. World Biologics Contract Manufacturing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Biologics Contract Manufacturing Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Biologics Contract Manufacturing Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Biologics Contract Manufacturing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Biologics Contract Manufacturing Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Biologics Contract Manufacturing Market Size by Application (2024-2029) & (USD Million)
    Table 35. Lonza Group Basic Information, Area Served and Competitors
    Table 36. Lonza Group Major Business
    Table 37. Lonza Group Biologics Contract Manufacturing Product and Services
    Table 38. Lonza Group Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Lonza Group Recent Developments/Updates
    Table 40. Lonza Group Competitive Strengths & Weaknesses
    Table 41. Samsung Biologics Co., Ltd. Basic Information, Area Served and Competitors
    Table 42. Samsung Biologics Co., Ltd. Major Business
    Table 43. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Services
    Table 44. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Samsung Biologics Co., Ltd. Recent Developments/Updates
    Table 46. Samsung Biologics Co., Ltd. Competitive Strengths & Weaknesses
    Table 47. Thermo Fisher Scientific, Inc. Basic Information, Area Served and Competitors
    Table 48. Thermo Fisher Scientific, Inc. Major Business
    Table 49. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product and Services
    Table 50. Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Thermo Fisher Scientific, Inc. Recent Developments/Updates
    Table 52. Thermo Fisher Scientific, Inc. Competitive Strengths & Weaknesses
    Table 53. Cambrex Corporation Basic Information, Area Served and Competitors
    Table 54. Cambrex Corporation Major Business
    Table 55. Cambrex Corporation Biologics Contract Manufacturing Product and Services
    Table 56. Cambrex Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Cambrex Corporation Recent Developments/Updates
    Table 58. Cambrex Corporation Competitive Strengths & Weaknesses
    Table 59. Siegfried Holding AG Basic Information, Area Served and Competitors
    Table 60. Siegfried Holding AG Major Business
    Table 61. Siegfried Holding AG Biologics Contract Manufacturing Product and Services
    Table 62. Siegfried Holding AG Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Siegfried Holding AG Recent Developments/Updates
    Table 64. Siegfried Holding AG Competitive Strengths & Weaknesses
    Table 65. Fujifilm Holding Corporation Basic Information, Area Served and Competitors
    Table 66. Fujifilm Holding Corporation Major Business
    Table 67. Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Services
    Table 68. Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Fujifilm Holding Corporation Recent Developments/Updates
    Table 70. Fujifilm Holding Corporation Competitive Strengths & Weaknesses
    Table 71. AbbVie, Inc. Basic Information, Area Served and Competitors
    Table 72. AbbVie, Inc. Major Business
    Table 73. AbbVie, Inc. Biologics Contract Manufacturing Product and Services
    Table 74. AbbVie, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. AbbVie, Inc. Recent Developments/Updates
    Table 76. AbbVie, Inc. Competitive Strengths & Weaknesses
    Table 77. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 78. Boehringer Ingelheim Major Business
    Table 79. Boehringer Ingelheim Biologics Contract Manufacturing Product and Services
    Table 80. Boehringer Ingelheim Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Boehringer Ingelheim Recent Developments/Updates
    Table 82. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 83. Recipharm Pharmaceuticals Basic Information, Area Served and Competitors
    Table 84. Recipharm Pharmaceuticals Major Business
    Table 85. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Services
    Table 86. Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Recipharm Pharmaceuticals Recent Developments/Updates
    Table 88. Recipharm Pharmaceuticals Competitive Strengths & Weaknesses
    Table 89. WuXi Biologics Basic Information, Area Served and Competitors
    Table 90. WuXi Biologics Major Business
    Table 91. WuXi Biologics Biologics Contract Manufacturing Product and Services
    Table 92. WuXi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. WuXi Biologics Recent Developments/Updates
    Table 94. Catalent, Inc. Basic Information, Area Served and Competitors
    Table 95. Catalent, Inc. Major Business
    Table 96. Catalent, Inc. Biologics Contract Manufacturing Product and Services
    Table 97. Catalent, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of Biologics Contract Manufacturing Upstream (Raw Materials)
    Table 99. Biologics Contract Manufacturing Typical Customers
List of Figure
    Figure 1. Biologics Contract Manufacturing Picture
    Figure 2. World Biologics Contract Manufacturing Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Biologics Contract Manufacturing Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Biologics Contract Manufacturing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Biologics Contract Manufacturing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Biologics Contract Manufacturing Revenue (2018-2029) & (USD Million)
    Figure 13. Biologics Contract Manufacturing Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Biologics Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Biologics Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Biologics Contract Manufacturing by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics Contract Manufacturing Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics Contract Manufacturing Markets in 2022
    Figure 27. United States VS China: Biologics Contract Manufacturing Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Biologics Contract Manufacturing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Biologics Contract Manufacturing Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Biologics Contract Manufacturing Market Size Market Share by Type in 2022
    Figure 31. Monoclonal Antibodies
    Figure 32. Recombinant Proteins
    Figure 33. Vaccines
    Figure 34. Molecular Therapy
    Figure 35. Others
    Figure 36. World Biologics Contract Manufacturing Market Size Market Share by Type (2018-2029)
    Figure 37. World Biologics Contract Manufacturing Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Biologics Contract Manufacturing Market Size Market Share by Application in 2022
    Figure 39. Medical Company
    Figure 40. Hospital
    Figure 41. Biologics Contract Manufacturing Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonza Group
Samsung Biologics Co., Ltd.
Thermo Fisher Scientific, Inc.
Cambrex Corporation
Siegfried Holding AG
Fujifilm Holding Corporation
AbbVie, Inc.
Boehringer Ingelheim
Recipharm Pharmaceuticals
WuXi Biologics
Catalent, Inc.

Related Reports

Global Biologics Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Biologics Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Sep 2023

date Service & Software

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Biologics Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Biologics Contract Manufacturing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

Global Biologics Contract Manufacturing Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Service & Software

The global Biologics Contract Manufacturing market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Biologics Contract Manufacturing

Biologics Contract Manufacturing Service

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>